Jonas Engler

Jonas Engler

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMatthias Schmidt
Matthias Schmidt
SWSebastian Wiese
Sebastian Wiese
VAVolkan Adak
Volkan Adak
JEJonas Engler
Jonas Engler
SAShubhangi Agarwal
Shubhangi Agarwal
MFMarcus Fändrich
Marcus Fändrich
ATTR amyloidosis is one of the worldwide most abundant forms of systemic amyloidosis. The disease is caused by the misfolding of transthyretin protein and the formation of amyloid deposits at different sites within the body. Here, we present a 2.97 Å cryo electron microscopy structure of a fibril purified from the tissue of a patient with hereditary Val30Met ATTR amyloidosis. The fibril consists of a single protofilament that is formed from an N-terminal and a C-terminal fragment of transthyretin. Our structure provides insights into the mechanism of misfolding and implies the formation of an early fibril state from unfolded transthyretin molecules, which upon proteolysis converts into mature ATTR amyloid fibrils.

Verified
Journal Article
Open access
PDF file
AFAdriana Fontes
Adriana Fontes
AJAdrian T. Jauch
Adrian T. Jauch
JSJudith Sailer
Judith Sailer
JEJonas Engler
Jonas Engler
AAAnabela Marisa Azul
Anabela Marisa Azul
HZHans Zischka
Hans Zischka
Essential transition metals have key roles in oxygen transport, neurotransmitter synthesis, nucleic acid repair, cellular structure maintenance and stability, oxidative phosphorylation, and metabolism. The balance between metal deficiency and excess is typically ensured by several extracellular and intracellular mechanisms involved in uptake, distribution, and excretion. However, provoked by either intrinsic or extrinsic factors, excess iron, zinc, copper, or manganese can lead to cellular damage upon chronic or acute exposure, frequently attributed to oxidative stress. Intracellularly, mitochondria are the organelles that require the tightest control concerning reactive oxygen species production, which inevitably leaves them to be one of the most vulnerable targets of metal toxicity. Current therapies to counteract metal overload are focused on chelators, which often cause secondary effects decreasing patients’ quality of life. New therapeutic options based on synthetic or natural antioxidants have proven positive effects against metal intoxication. In this review, we briefly address the cellular metabolism of transition metals, consequences of their overload, and current therapies, followed by their potential role in inducing oxidative stress and remedies thereof.

9 May 2024 in Journal of the American Chemical Society
Verified
Journal Article
Open access
SSSaba Suladze
Saba Suladze
CMChristian Sustay Martinez
Christian Sustay Martinez
DCDiana C. Rodriguez Camargo
Diana C. Rodriguez Camargo
JEJonas Engler
Jonas Engler
NRNatalia Rodina
Natalia Rodina
BRBernd Reif
Bernd Reif
The deposition of islet amyloid polypeptide (hIAPP) fibrils is a hallmark of β-cell death in type II diabetes. In this study, we employ state-of-the-art MAS solid-state spectroscopy to investigate the previously elusive N-terminal region of hIAPP fibrils, uncovering both rigidity and heterogeneity. Comparative analysis between wild-type hIAPP and a disulfide-deficient variant (hIAPPC2S,C7S) unveils shared fibril core structures yet strikingly distinct dynamics in the N-terminus. Specifically, the variant fibrils exhibit extended β-strand conformations, facilitating surface nucleation. Moreover, our findings illuminate the pivotal roles of specific residues in modulating secondary nucleation rates. These results deepen our understanding of hIAPP fibril assembly and provide critical insights into the molecular mechanisms underpinning type II diabetes, holding promise for future therapeutic strategies.

4 December 2025 in Biomedicine & Pharmacotherapy
Verified
Journal Article
Open access
JEJonas Engler
Jonas Engler
EKEun-Jung Kim
Eun-Jung Kim
DKDasol Kim
Dasol Kim
NSNoreene M. Shibata
Noreene M. Shibata
ELEmilie Munk Lynderup
Emilie Munk Lynderup
HZHans Zischka
Hans Zischka
In Wilson disease (WD), excess copper provokes hepatocyte death due to impaired copper excretion, ultimately causing either acute or chronic liver damage. Current therapeutic compounds fail to reduce hepatic copper near to physiological levels, leaving lifelong, several times daily treatment as the only choice for patients. We have previously shown that a bacteria-derived methanobactin, termed ARBM-101, most efficiently depleted excess liver copper in still healthy WD rats. Here we report, for the first time, that mechanistically this is due to endosomal/lysosomal/exosomal trafficking of ARBM-101 in WD hepatocytes, allowing for copper mass excretion via the biliary/fecal route. We further show that such liver copper excretion occurs within minutes in vivo to detect copper-bound ARBM-101 in feces. This efficacy allows for specialized treatment regimen to rescue acute liver failure in WD rats. Moreover, also shown for the first time, it avoids fibrosis development in WD mice. Thus, judging from the results in two rodent species and human hepatocytes, this study advocates the development of ARBM-101 for WD therapy.

19 September 2026 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JSJudith Sailer
Judith Sailer
JGJonas Gottal
Jonas Gottal
.K.Leon Kaub
.Leon Kaub
AJAdrian T. Jauch
Adrian T. Jauch
JEJonas Engler
Jonas Engler
HZHans Zischka
Hans Zischka
A long-standing clinical conundrum is the pronounced phenotypic heterogeneity of hereditary hemochromatosis. Patients with identical HFE genotypes and similar degrees of iron overload can have vastly different clinical outcomes, ranging from being completely asymptomatic to developing severe cirrhosis, diabetes, or cardiomyopathy. This variability strongly implies the existence of genetic or environmental modifiers that dictate disease penetrance. Here, copper may be a compelling disease-modifying candidate, due to its intimately intertwined metabolism with iron. Indeed, profound iron loading in hemochromatosis mice ( Hfe knockout) and hemochromatosis Huh7 hepatocytes does not cause overt toxicity. However, the addition of copper, even in trace amounts and harmless on its own, dramatically amplifies adverse effects to induce profound cell toxicity. We find that copper-provoked iron vulnerability is not driven by Fenton chemistry-driven ROS damage, but instead induces a cuproptotic-like mechanism, characterized by proteotoxic stress, loss of iron-sulfur cluster enzyme activity, and severe mitochondrial dysfunction. Remarkably, high-affinity copper chelation rescued Huh7 cells, whereas inhibition of other canonical cell death pathways did not. These findings spotlight copper as a critical modifier in iron overload toxicity, capable of converting largely compensated iron overload into severe cellular injury and death, thereby providing a mechanistic explanation for the phenotypic heterogeneity in hemochromatosis.